Skip to main content
Isomorphic LabsFunding

Isomorphic Labs announces Series B investment round.

What happened

Isomorphic Labs Limited received financing of $2.1B in Series B on May 12th '26.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Isomorphic Labs announces Series B investment round. May 12, 2026 Isomorphic Labs announces it has raised $2.1 Billion in Series B funding. The financing round is led by Thrive Capital, and includes participation from existing backers Alphabet and GV alongside new investors MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, significantly expanding Isomorphic Labs' global capital base. Isomorphic Labs was founded with the ambition to leverage the power of AI to reimagine and accelerate drug discovery to bring much-needed treatments to millions of patients globally. The company aims to apply its pioneering AI drug design engine (IsoDDE) to deliver biomedical breakthroughs and is advancing drug design programs across multiple therapeutic areas and drug modalities. Read more in the news release below. Isomorphic Labs announces. $2.1 Billion funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.

isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-invest...Read the full source

Extracted by Autobound

From the Signal API record
Event
Funding

What this signalsNew funding often brings new budget and vendor reviews.

Amount
$2.1B
Takes effect
May 12, 2026
Location
Abu Dhabi, United Arab Emirates
Round
Series B
Financing type
Equity

The full record

From the Signal API record

Numbers

Amount (USD)
$2.1B

Extraction

Confidence
79%
Detected
May 13, 2026
signal_type
news
signal_subtype
receives_financing

Use this data

Get every funding signal for Isomorphic Labs and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Isomorphic Labs this week?”

  2. Send it to your own tools

    The Signal API returns funding signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/352e69af-4f05-4229-99b6-acaa74dd0536 returns this record as JSON. POST /v1/companies/enrich returns every signal for isomorphiclabs.com.

{
  "signal_id": "352e69af-4f05-4229-99b6-acaa74dd0536",
  "signal_type": "news",
  "signal_subtype": "receives_financing",
  "detected_at": "2026-05-13T00:00:00+00:00",
  "company": {
    "name": "Isomorphic Labs",
    "domain": "isomorphiclabs.com"
  },
  "data": {
    "url": "https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-investment-round",
    "title": "Isomorphic Labs announces Series B investment round.",
    "excerpt": "Isomorphic Labs announces Series B investment round.\n\nMay 12, 2026\n\nIsomorphic Labs announces it has raised $2.1 Billion in Series B funding. The financing round is led by Thrive Capital, and includes participation from existing backers Alphabet and GV alongside new investors MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, significantly expanding Isomorphic Labs' global capital base.\n\nIsomorphic Labs was founded with the ambition to leverage the power of AI to reimagine and accelerate drug discovery to bring much-needed treatments to millions of patients globally. The company aims to apply its pioneering AI drug design engine (IsoDDE) to deliver biomedical breakthroughs and is advancing drug design programs across multiple therapeutic areas and drug modalities.\n\nRead more in the news release below.\n\nIsomorphic Labs announces.\n\n$2.1 Billion funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.",
    "summary": "Isomorphic Labs Limited received financing of $2.1B in Series B on May 12th '26.",
    "location": "Abu Dhabi, United Arab Emirates, Western Asia, Asia",
    "planning": false,
    "image_url": "https://cdn.prod.website-files.com/6846c7b5a78f3e9225c64f10/6a02fe4a453fe60fef71201f_Web1.jpg",
    "confidence": 0.7873,
    "published_at": "2026-05-12T00:00:00Z",
    "location_data": [
      {
        "city": "Abu Dhabi",
        "region": "Western Asia",
        "country": "United Arab Emirates",
        "continent": "Asia",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-05-12",
    "article_sentence": "Isomorphic Labs announces it has raised $2.1 Billion in Series B funding.",
    "amount_normalized": 2100000000,
    "financing_type_tags": [
      "equity"
    ],
    "financing_type_normalized": "Series B"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.